Synaptic plasticity in animal models of early Alzheimer's disease
- PMID: 12740129
- PMCID: PMC1693153
- DOI: 10.1098/rstb.2002.1240
Synaptic plasticity in animal models of early Alzheimer's disease
Abstract
Amyloid beta-protein (Abeta) is believed to be a primary cause of Alzheimer's disease (AD). Recent research has examined the potential importance of soluble species of Abeta in synaptic dysfunction, long before fibrillary Abeta is deposited and neurodegenerative changes occur. Hippocampal excitatory synaptic transmission and plasticity are disrupted in transgenic mice overexpressing human amyloid precursor protein with early onset familial AD mutations, and in rats after exogenous application of synthetic Abeta both in vitro and in vivo. Recently, naturally produced soluble Abeta was shown to block the persistence of long-term potentiation (LTP) in the intact hippocampus. Sub-nanomolar concentrations of oligomeric Abeta were sufficient to inhibit late LTP, pointing to a possible reason for the sensitivity of hippocampus-dependent memory to impairment in the early preclinical stages of AD. Having identified the active species of Abeta that can play havoc with synaptic plasticity, it is hoped that new ways of targeting early AD can be developed.
Similar articles
-
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. doi: 10.1042/BST0330563. Biochem Soc Trans. 2005. PMID: 16042545 Review.
-
Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity.Exp Gerontol. 2004 Nov-Dec;39(11-12):1661-7. doi: 10.1016/j.exger.2004.06.020. Exp Gerontol. 2004. PMID: 15582282
-
Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.Brain. 2008 Sep;131(Pt 9):2414-24. doi: 10.1093/brain/awn174. Epub 2008 Aug 4. Brain. 2008. PMID: 18678563
-
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.Eur J Neurosci. 2006 Apr;23(8):2035-47. doi: 10.1111/j.1460-9568.2006.04733.x. Eur J Neurosci. 2006. PMID: 16630051
-
Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.Biochem Soc Trans. 2007 Nov;35(Pt 5):1219-23. doi: 10.1042/BST0351219. Biochem Soc Trans. 2007. PMID: 17956317 Review.
Cited by
-
Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.J Alzheimers Dis. 2016 Apr 12;52(4):1373-83. doi: 10.3233/JAD-160110. J Alzheimers Dis. 2016. PMID: 27079723 Free PMC article.
-
Pathway-specific alteration of synaptic plasticity in Tg2576 mice.Mol Cells. 2011 Aug;32(2):197-201. doi: 10.1007/s10059-011-0077-8. Epub 2011 Jun 1. Mol Cells. 2011. PMID: 21638202 Free PMC article.
-
Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response.Brain Commun. 2024 Sep 27;6(5):fcae333. doi: 10.1093/braincomms/fcae333. eCollection 2024. Brain Commun. 2024. PMID: 39391333 Free PMC article.
-
Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity.Front Aging Neurosci. 2024 Aug 5;16:1428244. doi: 10.3389/fnagi.2024.1428244. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39161341 Free PMC article. Review.
-
Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia.Neurology. 2008 May 6;70(19 Pt 2):1763-70. doi: 10.1212/01.wnl.0000281689.28759.ab. Epub 2007 Dec 12. Neurology. 2008. PMID: 18077800 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical